Irbesartan Accord

Irbesartan, the active ingredient in Irbesartan Accord, is an angiotensin II receptor antagonist presented as an oral tablet for oral use. It treats hypertension and diabetic nephropathy in adult patients. GNH USA supplies Irbesartan Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Irbesartan is used to manage conditions that involve the renin‑angiotensin system.

Hypertension: lowers blood pressure and reduces the risk of cardiovascular events. Diabetic nephropathy: slows the progression of kidney damage in patients with type 2 diabetes.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue - Nausea or abdominal discomfort - Elevated blood potassium levels - Mild cough

Serious or Rare Side Effects: - Angioedema (swelling of face, lips, tongue) - Severe hypotension - Acute kidney injury or worsening renal function - Hepatic injury (elevated liver enzymes) - Neutropenia or agranulocytosis - Anaphylactic reactions

Before initiating therapy, clinicians should assess individual risk factors and monitor relevant parameters.

Monitor blood pressure: adjust dose to achieve target levels. Assess renal function: check serum creatinine and eGFR periodically. Check electrolytes: especially potassium levels. Use caution in hepatic impairment: dose may need adjustment. Avoid use in pregnancy: potential fetal toxicity. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Irbesartan may interact with several medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Aliskiren in patients with diabetes: increased risk of renal dysfunction. - Potassium‑sparing diuretics or supplements: risk of hyperkalaemia. - ACE inhibitors: additive effect on potassium and renal function. - Lithium: may increase lithium concentrations. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise irbesartan levels.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may enhance antihypertensive effect. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): monitor renal function and blood pressure. - Other antihypertensives: adjust dose to avoid excessive hypotension.